Novo Nordisk says Catalent buyout to close soon as regulatory conditions met

1 bulan yang lalu

Healthcare
M&A

, ,

Novo Nordisk (NVO) announced Saturday that its pending acquisition of 3 Catalent (NYSE:CTLT) accumulation sites is expected to adjacent wrong days arsenic its genitor entity satisfied each regulatory conditions to bargain nan U.S. statement manufacturer.

The announcement followed nan U.S. Federal